Literature DB >> 1243993

Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment.

A Handforth, T L Sourkes.   

Abstract

The increase in the dopamine (DA) concentration of rat (whole) brain induced by gamma-hydroxybutyrate was inhibited by the reputed dopamine agonists apomorphine, apocodeine, 2-bromo-alpha-ergocryptine, piribedil, ergocornine and 5,6-dihydroxy-2-dimethylaminotetralin. The last three drugs raised DA levels in saline controls. Haloperidol, which decreased DA in controls slightly, prevented any agonist-induced rise in controls. However, haloperidol antagonized only apomorphine and piribedil in regard to the inhibition of the gamma-hydroxybutyrate induced rise in DA; this neuroleptic did not affect the inhibition by the other agonists. It is concluded that these data provide evidence for local receptor control of DA synthesis and that the DA agonists do not act through a common mechanism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1243993     DOI: 10.1016/0014-2999(75)90257-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.

Authors:  P C Waldmeier; J Lauber; W Blum; W J Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

2.  Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum.

Authors:  M G Feenstra; H Rollema; A S Horn; D Dijkstra; C J Grol; B H Westerink; A Westerbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-01       Impact factor: 3.000

3.  Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.

Authors:  N E Andén; M Grabowska-Andén; B Liljenberg
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

4.  Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.

Authors:  G Gianutsos; J E Thornburg; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1976-11-24       Impact factor: 4.530

5.  The effect of gamma-hydroxybutyrate on mouse striatal tyramine, dopamine and homovanillic acid.

Authors:  A V Juorio
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

6.  Neurochemical and behavioural profiles of five dopamine analogues.

Authors:  C Sumners; D Dijkstra; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-07       Impact factor: 3.000

7.  Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain.

Authors:  R W Fuller; K W Perry
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Dopaminergic properties of mesulergine (CU 32-085) and its metabolites.

Authors:  A Enz; P Donatsch; R Nordmann
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

Review 9.  Seeding of proteins into amyloid structures by metabolite assemblies may clarify certain unexplained epidemiological associations.

Authors:  Dorin Sade; Shira Shaham-Niv; Zohar A Arnon; Omid Tavassoly; Ehud Gazit
Journal:  Open Biol       Date:  2018-01       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.